Video

How PQA Identified the Need for New Opioid Measures

Lisa Hines, PharmD, vice president of Measurement and Operations at Pharmacy Quality Alliance (PQA), discusses the alliance's new opioid measures and how PQA identified the need for them during the PQA Annual Meeting in Baltimore, MD.

Lisa Hines, PharmD, vice president of Measurement and Operations at Pharmacy Quality Alliance (PQA), discusses the alliance's new opioid measures and how PQA identified the need for them during the PQA Annual Meeting in Baltimore, MD.

Lisa Hines, PharmD: So, we identified the gaps for these measures from the existing evidence showing that this was a problem, and that it was correlated with bad outcomes. And, also the measures are aligned with the CDC Opioid Prescribing Guidelines, and we just found that there was a gap for existing measurement, to address this epidemic.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Related Videos
Magnified bone marrow biopsy showing plasma cells with irregular nuclei and multiple myeloma tumor cells infiltrating normal hematopoietic tissue
Health and nutrition: the role of glp-1 in diabetes management with apple and syringe - Image credit: Thanayut | stock.adobe.com
Image credit: Dr_Microbe | stock.adobe.com
Image credit: K KStock | stock.adobe.com
Image credit: komokvm | stock.adobe.com
Vial of Pneumococcal vaccine - Image credit: Bernard Chantal | stock.adobe.com
Vaccine vials used for Respiratory Syncytial Virus (RSV) with a syringe - Image credit:  Peter Hansen | stock.adobe.com